Human BRAF Gene V600E Ukuguqulwa
Igama lomkhiqizo
I-HWTS-TM007-Human BRAF Gene V600E Mutation Detection Kit(Fluorescence PCR)
Isitifiketi
CE/TFDA
I-Epidemiology
Zingaphezu kwama-30 izinhlobo zokuguqulwa kwe-BRAF ezitholakele, cishe u-90% wazo zitholakala ku-exon 15, lapho ukuguqulwa kwe-V600E kuthathwa njengokujwayelekile kakhulu, okungukuthi, i-thymine(T) esendaweni 1799 ku-exon 15 iguqulelwe ku- i-adenine (A), okuholela ekushintshweni kwe-valine (V) endaweni engu-600 nge-glutamic acid (E) emkhiqizweni wamaprotheni.Ukuguqulwa kwe-BRAF kuvame ukutholakala ezimila eziyingozi njengemelanoma, umdlavuza we-colorectal, umdlavuza wegilo, nomdlavuza wamaphaphu.Ukuqonda ukuguqulwa kofuzo lwe-BRAF sekuyisidingo sokuhlola izidakamizwa ze-EGFR-TKIs kanye ne-BRAF eqondiswe kokuguqulwa kofuzo ekwelashweni kwezidakamizwa okuhlosiwe ezigulini ezingazuza.
Isiteshi
FAM | Ukuguqulwa kwe-V600E, ukulawula kwangaphakathi |
Imingcele Yezobuchwepheshe
Isitoreji | ≤-18℃ |
Impilo yeshelufu | 9 izinyanga |
Uhlobo lwesifanekiso | amasampula ezicubu ze-pathological afakwe upharafini |
CV | <5.0% |
Ct | ≤38 |
LoD | Sebenzisa amakhithi ukuthola ukulawulwa kwekhwalithi okuhambisanayo kwe-LoD.a) ngaphansi kuka-3ng/μL ingemuva lohlobo lwasendle, izinga lokuguqulwa elingu-1% lingatholwa kusigcinalwazi sokusabela ngokuzinzile;b) ngaphansi kwesilinganiso esingu-1% sokuguqulwa, ukuguqulwa kwe-1 × 103Amakhophi/mL kungemuva lohlobo lwasendle lwe-1×105Amakhophi/mL angatholwa ngokuzinza kusigcinalwazi sokusabela;c) I-IC Reaction Buffer ingathola umkhawulo wokuthola umkhawulo ophansi wokulawula ikhwalithi SW3 wokulawula kwangaphakathi kwenkampani. |
Izinsimbi Ezisebenzayo: | I-Applied Biosystems 7500 Real-Time PCR SystemsI-Applied Biosystems 7300 Real-Time PCR Amasistimu, I-QuantStudio® 5 Real-Time PCR Systems Uhlelo lwe-PCR lwe-LightCycler®480 Real-Time I-BioRad CFX96 Real-Time PCR System |
Ukugeleza komsebenzi
Ama-reagents okukhipha anconyiwe: I-QIAGEN's QIAamp DNA FFPE Tissue Kit (56404), I-Tissue DNA Rapid Extraction Kit eshumekwe Upharafini (DP330) ekhiqizwe i-Tiangen Biotech(Beijing) Co., Ltd.